Enoblituzumab Plus MGA012 or MGD013 in Squamous Cell Carcinoma of the Head and Neck

Clinical trial NCT04129320 · WITHDRAWN

Trial details

NCT number: NCT04129320
Sponsor: MacroGenics
Status: WITHDRAWN
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Head and Neck Cancer Squamous Cell Carcinoma of Head and Neck

Start date: 2019-10-01
Primary completion: 2020-10-01
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.